Annual report
5194.TEDINET S100W6AQ
Period2024-04-01 → 2025-03-31
Filed2025-06-26
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥5.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥6.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥6.0bn | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.4bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.6bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | −¥34m | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥436m | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥523m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥389m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.1bn | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.5bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.0bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥622m | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥357m | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥393m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥41m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥674m | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.1bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥598m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥377m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥2m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥18.6bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥17.7bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥18.1bn | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥17.0bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥15.7bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.5bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥7.6bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥11.1bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥10.1bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥9.9bn | at 2023-03-31d | Cons. | Net assets |
| Net assets / equity | ¥8.9bn | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥7.6bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.9bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.2bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.9bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.8bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.5bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥790m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥374m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥899m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥905m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.4bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥438m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥133m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥185m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥676m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥503m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥907m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥422m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥190m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥671m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥36.16 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥3.77 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥62.04 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥101.1 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.08 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥998.29 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥906.81 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥889.52 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥797.34 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥675.55 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 58.2% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.6% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.2% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.8% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.7% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 3.8% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 0.4% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 13.7% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.4% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 790 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 854 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 809 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 796 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 871 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥5.7bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥6.1bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥5.9bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥5.8bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥5.5bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥640m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥987m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥691m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.0bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.1bn | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥793m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.0bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥557m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥683m | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥757m | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥690m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥770m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥17.0bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥16.6bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥16.4bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥15.9bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥16.4bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.1bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥5.3bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥11.8bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥11.3bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥10.5bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥9.8bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥9.2bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.3bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥491m | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥51.34 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥62.95 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥69.71 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥63.58 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥70.95 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥10 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥10 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,090.72 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,039.55 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥968.63 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥905.27 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥851.12 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 69.8% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.9% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.3% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.7% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.3% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 4.8% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.3% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.2% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.7% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 10,937,000 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,937,000 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,937,000 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,937,000 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,937,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 200 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 197 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 195 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 207 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 207 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 76
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2024-04-01 → 2025-03-31 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2024-04-01 → 2025-03-31 | ¥8m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2025-03-31 | 31 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2025-03-31 | ¥158m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2025-03-31 | ¥158m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2025-03-31 | ¥182m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2025-03-31 | −¥74m |
| Reconciling Itemsreconciling | capex | 2024-04-01 → 2025-03-31 | ¥9m |
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥10m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥2.2bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥487m |
| Health Care Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥90m |
| Health Care Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥670m |
| Health Care Businessreportable segment | employees | at 2025-03-31 | 681 pure |
| Health Care Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥4.3bn |
| Health Care Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥4.3bn |
| Health Care Businessreportable segment | segment assets | at 2025-03-31 | ¥15.3bn |
| Health Care Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥611m |
| Plastic Products Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥32m |
| Plastic Products Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥18m |
| Plastic Products Businessreportable segment | employees | at 2025-03-31 | 55 pure |
| Plastic Products Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.3bn |
| Plastic Products Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥1.3bn |
| Plastic Products Businessreportable segment | segment assets | at 2025-03-31 | ¥923m |
| Plastic Products Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | −¥84m |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥123m |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥689m |
| —segment total | employees | at 2025-03-31 | 736 pure |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥5.5bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥5.5bn |
| —segment total | segment assets | at 2025-03-31 | ¥16.2bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥527m |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥124m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥697m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥5.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥5.7bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥16.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥453m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2023-04-01 → 2024-03-31 | ¥889,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2023-04-01 → 2024-03-31 | ¥9m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2024-03-31 | ¥209m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2024-03-31 | ¥209m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2024-03-31 | ¥264m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2024-03-31 | −¥91m |
| Reconciling Itemsreconciling | capex | 2023-04-01 → 2024-03-31 | ¥7m |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥12m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥1.3bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2024-03-31 | −¥454m |
| Health Care Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥108m |
| Health Care Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥623m |
| Health Care Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥4.7bn |
| Health Care Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥4.7bn |
| Health Care Businessreportable segment | segment assets | at 2024-03-31 | ¥15.2bn |
| Health Care Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥979m |
| Plastic Products Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥6m |
| Plastic Products Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥14m |
| Plastic Products Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥1.2bn |
| Plastic Products Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥1.2bn |
| Plastic Products Businessreportable segment | segment assets | at 2024-03-31 | ¥971m |
| Plastic Products Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥3m |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥114m |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥637m |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥5.9bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥5.9bn |
| —segment total | segment assets | at 2024-03-31 | ¥16.2bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥981m |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-04-01 → 2024-03-31 | ¥115m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-04-01 → 2024-03-31 | ¥646m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥6.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥6.1bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-03-31 | ¥16.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2024-03-31 | ¥891m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2025-03-31 | 31 pure |
| Health Care Businessreportable segment | employees | at 2025-03-31 | 91 pure |
| Plastic Products Businessreportable segment | employees | at 2025-03-31 | 55 pure |
| —segment total | employees | at 2025-03-31 | 146 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,513
| Item | Context | Value | Unit |
|---|---|---|---|
| Land | Prior1YearInstant | 1069970000 | JPY |
| Land | CurrentYearInstant | 676629000 | JPY |
| Construction in progress | Prior1YearInstant | 56006000 | JPY |
| Construction in progress | CurrentYearInstant | 90117000 | JPY |
| Other ppe | Prior1YearInstant | 324404000 | JPY |
| Other ppe | CurrentYearInstant | 361394000 | JPY |
| Accumulated depreciation other ppe | Prior1YearInstant | -232500000 | JPY |
| Accumulated depreciation other ppe | CurrentYearInstant | -259900000 | JPY |
| Other net ppe | Prior1YearInstant | 91904000 | JPY |
| Other net ppe | CurrentYearInstant | 101494000 | JPY |
| Property plant and equipment | Prior1YearInstant | 10910010000 | JPY |
| Property plant and equipment | CurrentYearInstant | 11302153000 | JPY |
| Intangible assets | Prior1YearInstant | 7693000 | JPY |
| Intangible assets | CurrentYearInstant | 6259000 | JPY |
| Investment securities | Prior1YearInstant | 804741000 | JPY |
| Investment securities | CurrentYearInstant | 969539000 | JPY |
| Deferred tax assets | Prior1YearInstant | 29175000 | JPY |
| Deferred tax assets | CurrentYearInstant | － | JPY |
| Net defined benefit asset | Prior1YearInstant | 44706000 | JPY |
| Net defined benefit asset | CurrentYearInstant | 45625000 | JPY |
| Other ioa | Prior1YearInstant | 85923000 | JPY |
| Other ioa | CurrentYearInstant | 61716000 | JPY |
| Allowance for doubtful accounts ioa by group | Prior1YearInstant | -619000 | JPY |
| Allowance for doubtful accounts ioa by group | CurrentYearInstant | -550000 | JPY |
| Investments and other assets | Prior1YearInstant | 963925000 | JPY |
| Investments and other assets | CurrentYearInstant | 1076331000 | JPY |
| Noncurrent assets | Prior1YearInstant | 11881629000 | JPY |
| Noncurrent assets | CurrentYearInstant | 12384744000 | JPY |
| Assets | Prior1YearInstant | 17716395000 | JPY |
| Assets | CurrentYearInstant | 18635686000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 310412000 | JPY |
| Notes and accounts payable trade | CurrentYearInstant | 190094000 | JPY |
| Electronically recorded obligations operating cl | Prior1YearInstant | 289359000 | JPY |
| Electronically recorded obligations operating cl | CurrentYearInstant | 236872000 | JPY |
| Short term loans payable | Prior1YearInstant | 5323927000 | JPY |
| Short term loans payable | CurrentYearInstant | 5515033000 | JPY |
| Income taxes payable | Prior1YearInstant | 161712000 | JPY |
| Income taxes payable | CurrentYearInstant | 102113000 | JPY |
| Advances received | Prior1YearInstant | 11187000 | JPY |
| Advances received | CurrentYearInstant | 205044000 | JPY |
| Provision for bonuses | Prior1YearInstant | 77575000 | JPY |
| Provision for bonuses | CurrentYearInstant | 81325000 | JPY |
| Other cl | Prior1YearInstant | 542600000 | JPY |
| Other cl | CurrentYearInstant | 507897000 | JPY |
| Current liabilities | Prior1YearInstant | 6716775000 | JPY |
| Current liabilities | CurrentYearInstant | 6838381000 | JPY |
| Long term loans payable | Prior1YearInstant | 420897000 | JPY |
| Long term loans payable | CurrentYearInstant | 140520000 | JPY |
| Long term guarantee deposited | Prior1YearInstant | 2000000 | JPY |
| Long term guarantee deposited | CurrentYearInstant | 3000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |